Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-005263
Filing Date
2025-04-23
Accepted
2025-04-23 16:06:56
Documents
20
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A gbio-20250604xdef14a.htm   iXBRL DEF 14A 1523702
2 GRAPHIC gbio-20250604xdef14a_a003.jpg GRAPHIC 6777
3 GRAPHIC gbio-20250604xdef14a_a016.jpg GRAPHIC 50511
4 GRAPHIC gbio-20250604xdef14a_bg001.jpg GRAPHIC 129481
5 GRAPHIC gbio-20250604xdef14a_bg002.jpg GRAPHIC 108262
  Complete submission text file 0001558370-25-005263.txt   3272125

Data Files

Seq Description Document Type Size
6 EX-101.SCH gbio-20250604.xsd EX-101.SCH 6804
7 EX-101.DEF gbio-20250604_def.xml EX-101.DEF 7237
8 EX-101.LAB gbio-20250604_lab.xml EX-101.LAB 14749
9 EX-101.PRE gbio-20250604_pre.xml EX-101.PRE 8461
22 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20250604xdef14a_htm.xml XML 335367
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39319 | Film No.: 25861475
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)